Up-regulation of the multidrug resistance genes, mrp1 and mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, spgp, in endotoxemic rat liver

被引:314
作者
Vos, TA
Hooiveld, GJEJ
Koning, HH
Childs, S
Meijer, DKF
Moshage, H
Jansen, PLM
Müller, M
机构
[1] Univ Groningen Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Ctr Pharm, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen Hosp, Groningen Inst Drug Studies, Ctr Pharm, Groningen, Netherlands
[3] Univ Groningen Hosp, Ctr Pharm, Div Pharmacokinet & Drug Delivery, Groningen, Netherlands
[4] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
关键词
D O I
10.1002/hep.510280625
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Endotoxin-induced cholestasis is mainly caused by an impaired canalicular secretion. Mrp2, the canalicular multispecific organic anion transporter, is strongly downregulated in this situation, and canalicular bile salt secretion is also reduced. We hypothesized that other adenosine triphosphate-binding cassette (ABC) transporters may compensate for the decreased transport activity to protect the cell from cytokine-induced oxidative damage. Therefore, we examined the expression of ABC-transport proteins in membrane fractions of whole liver and of isolated hepatocytes of endotoxin-treated rats and performed reverse-transcriptase polymerase chain reaction (RT-PCR) on mRNA isolated from these livers. In addition, the localization of these transporters was examined using confocal scanning laser microscopy. By 6 hours after endotoxin administration, we found a clear increase of mrp1 mRNA and protein, whereas mrp2 mRNA and protein were decreased. This was confirmed in isolated hepatocytes. In addition, mdr1b mRNA was strongly increased, whereas mdr1a and mdr2 mRNA did not change significantly. Both the mRNA and protein levels of the sister of P-glycoprotein (spgp), the recently cloned bile salt transporter, decreased. After endotoxin treatment, the normally sharply delineated canalicular staining of mrp2 and spgp had changed to a fuzzy pattern, suggesting localization in a subapical compartment, We conclude that endotoxin-induced cholestasis is caused by decreased mrp2 and spgp levels, as well as an abnormal localization of these proteins. The simultaneous up-regulation of mrp1 and mdr1b may confer resistance to hepatocytes against cytokine-induced metabolic stress.
引用
收藏
页码:1637 / 1644
页数:8
相关论文
共 50 条
[1]   The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes [J].
Auer, KL ;
Contessa, J ;
Brenz-Verca, S ;
Pirola, L ;
Rusconi, S ;
Cooper, G ;
Abo, A ;
Wymann, MP ;
Davis, RJ ;
Birrer, M ;
Dent, P .
MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (03) :561-573
[2]   Hepatocyte transport of bile acids and organic anions in endotoxemic rats: Impaired uptake and secretion [J].
Bolder, U ;
TonNu, HT ;
Schteingart, CD ;
Frick, E ;
Hofmann, AF .
GASTROENTEROLOGY, 1997, 112 (01) :214-225
[3]  
Buchler M, 1996, J BIOL CHEM, V271, P15091
[4]   DEXAMETHASONE PREVENTS THE GROWTH INHIBITORY EFFECTS OF RECOMBINANT TUMOR-NECROSIS-FACTOR IN A RAT HEPATOMA-CELL LINE REUBER-RC-3 - AN ASSOCIATION WITH THE CHANGES IN THE MESSENGER-RNA LEVELS FOR MULTIDRUG RESISTANCE GENE [J].
CHAPEKAR, MS ;
HUGGETT, AC ;
CHENG, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 181 (03) :1524-1531
[5]  
Childs S, 1998, CANCER RES, V58, P4160
[6]  
CHILDS S, 1995, CANCER RES, V55, P2029
[7]  
COLE SPC, 1994, CANCER RES, V54, P5902
[8]   HEPATOBILIARY SECRETION OF ORGANIC-COMPOUNDS - MOLECULAR MECHANISMS OF MEMBRANE-TRANSPORT [J].
ELFERINK, RPJO ;
MEIJER, DKF ;
KUIPERS, F ;
JANSEN, PLM ;
GROEN, AK ;
GROOTHUIS, GMM .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON BIOMEMBRANES, 1995, 1241 (02) :215-268
[9]   The role of mdr2 P-glycoprotein in hepatobiliary lipid transport [J].
Elferink, RPJO ;
Tytgat, GNJ ;
Groen, AK .
FASEB JOURNAL, 1997, 11 (01) :19-28
[10]   Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA [J].
Evers, R ;
Kool, M ;
van Deemter, L ;
Janssen, H ;
Calafat, J ;
Oomen, LCJM ;
Paulusma, CC ;
Elferink, RPJO ;
Baas, F ;
Schinkel, AH ;
Borsi, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (07) :1310-1319